Search company, investor...

Compare Pepper Bio vs Recursion

Customers evaluate the quality of Pepper Bio's products using the following success metrics.


Pepper Bio Logo

Pepper Bio is 6 yrs old and is based in United States.

Pepper Bio operates a drug discovery company. It provides actionable insight for drug research. It integrates phosphoproteomics, proteomics, transcriptomics, and genomics with a focus on neurodegenerative, inflammatory, and oncology therapeutics. The company was founded in 2018 and is based in Boston, Massachusetts.

Recursion Logo

Recursion is 11 yrs old and is based in United States.

Recursion (NASDAQ: RXRX) develops a clinical-stage biotechnology company. It combines experimental biology and automation with artificial intelligence (AI) in a parallel system to discover drugs for diverse indications such as genetic disease, inflammation, immunology, and infectious disease. It collaborates with biopharmaceutical companies to broadly explore diverse disease domains and identify novel therapeutic candidates. The company was founded in 2013 and is based in Salt Lake City, Utah.

Founded Year


United States
United States

Demo Video

Pepper Bio did not submit their demo in their Analyst Briefing

Work for Pepper Bio?

Demo not available because Recursion has not claimed their profile.

Work for Recursion? Show off your product.


Jon Hu (Founder, Chief Executive Officer)

See all 2 people

Christopher Gibson (Founder, Chief Executive Officer)

See all 5 people


Pepper Bio last raised $150K on 1/6/2023.
Recursion last raised $50M on 7/13/2023.


Seed VC - III
Corporate Minority - P2P - II

Total Raised



NVIDIA, Baillie Gifford & Co.

See all 5 investors


Why Pepper Bio beats Recursion

  • Global functional data via integration of phosphoproteomics provides us with a deep, mechanistic understanding of what’s going on. Recursion’s image-based approach will only capture results and not process. This difference allows Pepper to predict therapeutic responses in a more nuanced, comprehensive manner and ultimately results in drugs with better safety/efficacy profiles.

Information not available because Recursion has not claimed their profile.

Work for Recursion? Claim your profile by submitting an Analyst Briefing. By submitting you can

Show your primary competitive advantage
Highlight your competitive differentiation
Show why customers evalute your products
Explain why customers choose your products and services

Work for Recursion?

Claim your profile now.


  • Probability of success for programs we work on
  • Novel target identified
  • Novel MOA identified


  • COMPASS Platform

    Our bioplatform, COMPASS, uses proprietary lab methods and computational abilities to unlock a new level of sophistication in drug discovery. Like real-time navigation for drug discovery, we help partners find the safest, fastest route to new, effective drugs in clinical trials. So far, we have already identified applications of our technology for rare diseases in oncology, neurology, and inflammatory.

See all products


Pepper Bio works with 2 known companies.

Known Partners

Dean Felsher Laboratory, Cyclerion Therapeutics

Why They Buy

Pepper Bio did not submit their references in their Analyst Briefing

Work for Pepper Bio?

News & Analysis

Pepper Bio has not been mentioned in our research.

Recursion has been mentioned in our research 8 times.

Expert Collections


Digital Health

10,553 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.


Oncology Tech

457 items

This collection includes companies applying technology to cancer care, diagnosis, and treatment. Examples include vendors offering cancer detection and diagnosis, oncology clinical decision support, real-world data, and AI oncology drug discovery.


AI 100

299 items

Winners of CB Insights' annual AI 100, a list of the 100 most promising AI startups in the world.


Conference Exhibitors

5,501 items

HLTH is a healthcare event bringing together startups and large companies from pharma, health insurance, business intelligence, and more to discuss the shifting landscape of healthcare